Skip to content

The clinical and metabolic mechanisms of the "Tongtiao Dai Mai" acupuncture method combined with lifestyle intervention in the treatment of abdominal obesity

The clinical and metabolic mechanisms of the "Tongtiao Dai Mai" acupuncture method combined with lifestyle intervention in the treatment of abdominal obesity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001114
Enrollment
Unknown
Registered
2025-06-04
Start date
2025-04-08
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal obesity

Interventions

Lifestyle intervention group:Lifestyle interventions
Acupuncture + lifestyle intervention group:Acupuncture and lifestyle intervention
health volunteer:not

Sponsors

Dongfang Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of abdominal obesity patients ( 1 ) People who met the above diagnostic criteria and were diagnosed with abdominal obesity ; ( 2 ) Gender unlimited age 18-55 years old ( 3 ) Those who signed informed consent and voluntarily accepted the intervention method of this project. Note : Patients who meet the above three items at the same time can be included in this study. Inclusion criteria for healthy subjects : ( 1 ) Waist circumference in the normal range of the population that is male waist circumference < 90cm female waist circumference < 85cm ; ( 2 ) without heart liver kidney digestive tract respiratory blood nervous system and other diseases ; ( 3 ) Physical examination found no positive signs of clinical significance ; ( 4 ) regardless of gender aged 18-55 years old ; ( 5 ) The health examination items were normal ; ( 6 ) To sign informed consent and voluntarily accept the research method of this project. Note : People who meet the above 6 items at the same time can be included in this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients with abdominal obesity ( 1 ) exclusion of infectious diseases including a clear focus of infection or systemic infectious diseases ; ( 2 ) Exclude pregnant perinatal lactating menopausal women and women who plan to be pregnant within 24 weeks ; ( 3 ) Obesity caused by hypothyroidism hypothalamic pituitary disease Cushing 's syndrome polycystic ovary syndrome and other diseases ; ( 4 ) Malignant tumors cirrhosis and other serious primary diseases coronary heart disease stroke and other secondary cardiovascular and cerebrovascular events and patients with mental illness. ( 5 ) Have a history of clinical diagnosis of eating disorders such as bulimia excessive appetite anorexia etc. in the past three months weight fluctuations greater than 5Kg ; ( 6 ) In the past 3 months they have taken drugs known to affect weight or appetite such as weight loss drugs corticosteroids antidepressants diazepams non-selective systemic antihistamines nicotine substitutes hypoglycemic drugs etc. ; those who have plans to quit smoking or drinking ; ( 7 ) Those who have a history of surgical weight loss or have participated in clinical research on weight loss in the past six months or are taking drugs diet or exercise interventions to lose weight ; ( 8 ) Treatment of local skin ulceration metal Chinese medicine preparation allergy and suffering from other serious skin diseases ; ( 9 ) those who could not cooperate and persist during treatment and follow-up. Exclusion criteria for healthy subjects ( 1 ) pregnant lactating menopausal women or women with pregnancy plan within half a year ; ( 2 ) those who took the known drugs that had an impact on this study in the past six months ; ( 3 ) Participated in other clinical researchers in the past six months ; ( 4 ) Patients with primary diseases in important organs ; ( 5 ) patients with mental or physical disabilities ; ( 6 ) unable to cooperate with and adhere to the researcher.

Design outcomes

Primary

MeasureTime frame
Waist circumference;

Secondary

MeasureTime frame
Waist-hip ratio;Body weight;TCM Constitution Scale;Non-target metabolomics assays;Liver Elastography;Body mass index;Blood uric acid;Subcutaneous fat ;Total cholesterol;TCM syndrome scale;Hip circumference;High density lipoprotein cholesterol;Triglycerides;Low-density lipoprotein cholesterol;Maximum preperitoneal fat thickness;Abdominal wall fat index;Fasting C peptide;Fasting blood glucose;Percentage of body fat;Intra-abdominal fat thickness;Fasting insulin;Waist-height ratio;

Countries

China

Contacts

Public ContactLiang Cui-mei

Dongfang Hospital Beijing University of Chinese Medicine

dfzhenjiulcm@126.com18511284813

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026